Whitehawk Therapeutics, Inc. (WHWK) Tops Q4 EPS by 35c

March 12, 2026 8:35 AM EDT

Whitehawk Therapeutics, Inc. (NASDAQ: WHWK) reported Q4 EPS of ($0.34), $0.35 better than the analyst estimate of ($0.69).

For earnings history and earnings-related data on Whitehawk Therapeutics, Inc. (WHWK) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings, Maynard Um, Mark Zuckerberg, ARK